Clinical Trial Update: Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of Fruquintinib and Raltitrexed for metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: The First Affiliated Hospital of Nanchang University | Conditions: Metastatic Colorectal Cancer | Phase 4 | Status: RECRUITING